PROFOUND MED CORP's ticker is PROF and the CUSIP is 74319B502. A total of 46 filers reported holding PROFOUND MED CORP in Q3 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $78,887 | -1.1% | 7,734 | +26.1% | 0.00% | – |
| Q2 2023 | $79,803 | +67.3% | 6,134 | +19.4% | 0.00% | – |
| Q1 2023 | $47,713 | -33.4% | 5,136 | -21.9% | 0.00% | – |
| Q4 2022 | $71,602 | +146.9% | 6,575 | -9.0% | 0.00% | – |
| Q3 2022 | $29,000 | -42.0% | 7,222 | +5.5% | 0.00% | – |
| Q2 2022 | $50,000 | -30.6% | 6,847 | -14.6% | 0.00% | – |
| Q1 2022 | $72,000 | -27.3% | 8,019 | -8.6% | 0.00% | – |
| Q4 2021 | $99,000 | -14.7% | 8,769 | +10.4% | 0.00% | – |
| Q3 2021 | $116,000 | -75.6% | 7,941 | -72.7% | 0.00% | – |
| Q2 2021 | $476,000 | -55.8% | 29,084 | -45.6% | 0.00% | – |
| Q1 2021 | $1,077,000 | +17.6% | 53,463 | +20.0% | 0.00% | – |
| Q4 2020 | $916,000 | +28.5% | 44,570 | +10.3% | 0.00% | – |
| Q3 2020 | $713,000 | +246.1% | 40,401 | +231.7% | 0.00% | – |
| Q2 2020 | $206,000 | +59.7% | 12,180 | -7.6% | 0.00% | – |
| Q1 2020 | $129,000 | +290.9% | 13,188 | +331.0% | 0.00% | – |
| Q4 2019 | $33,000 | – | 3,060 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 341,767 | $7,029,000 | 13.80% |
| GAGNON SECURITIES LLC | 821,196 | $16,883,000 | 2.69% |
| Gagnon Advisors, LLC | 277,252 | $5,700,000 | 2.56% |
| Taylor Wealth Management Partners | 166,294 | $3,419,000 | 1.32% |
| PCJ Investment Counsel Ltd. | 126,930 | $2,611,000 | 1.22% |
| EAM Global Investors LLC | 172,291 | $3,542,000 | 0.96% |
| AWM Investment Company, Inc. | 348,939 | $7,174,000 | 0.91% |
| PURA VIDA INVESTMENTS, LLC | 780,567 | $16,048,000 | 0.58% |
| Wealth Management Partners, LLC | 20,282 | $554,000 | 0.43% |
| Parkman Healthcare Partners LLC | 69,049 | $1,420,000 | 0.36% |